Skip to main content
Clinical Trials/ACTRN12611000809932
ACTRN12611000809932
Not yet recruiting
未知

Analysis of the effectiveness in clinical practice of the use of polymethylmethacrylate membrane dialyzer as adjuvant in the treatment of dialysis patients in the course of Hepatitis B vaccination

SL 8 Arezzo P.O. Ospedale S. Donato di Arezzo0 sites40 target enrollmentAugust 2, 2011

Overview

Phase
未知
Intervention
Not specified
Conditions
End Stage Renal Disease patients immune system response to Hepatitis B vaccination
Sponsor
SL 8 Arezzo P.O. Ospedale S. Donato di Arezzo
Enrollment
40
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 2, 2011
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
SL 8 Arezzo P.O. Ospedale S. Donato di Arezzo

Eligibility Criteria

Inclusion Criteria

  • End Stage Renal desease patients on mainteinance thrice\-weekly dialysis treatment who had been defined as non\-responder to Hepatitis B vaccination according to CDC criteria

Exclusion Criteria

  • End Stage Renal desease patients on mainteinance thrice\-weekly dialysis treatment who had been defined as non responder to Hepatitis B vaccination according to CDC criteria already using any kind of polymethylmethacrylate membrane dialyzers at the initial time of observation

Outcomes

Primary Outcomes

Not specified

Similar Trials